We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.5B
AUM Growth
+$193M
Cap. Flow
-$192M
Cap. Flow %
-1.67%
Top 10 Hldgs %
54.02%
Holding
1,049
New
36
Increased
599
Reduced
353
Closed
55

Top Buys

Rank Stock Value
1
HESM icon
Hess Midstream
HESM
+$60.8M
2
CEQP
Crestwood Equity Partners LP
CEQP
+$23.6M
3
MPLX icon
MPLX
MPLX
+$18.5M
4
WES icon
Western Midstream Partners
WES
+$13.9M
5
NWL icon
Newell Brands
NWL
+$7.38M

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$128M
2
ENLC
ENLINK MIDSTREAM, LLC
ENLC
+$96.8M
3
PAA icon
Plains All American Pipeline
PAA
+$55.6M
4
EPD icon
Enterprise Products Partners
EPD
+$19.3M
5
MSFT icon
Microsoft
MSFT
+$10.1M

Sector Composition

Rank Sector Weight
1 Energy 64.17%
2 Technology 5.57%
3 Healthcare 3.84%
4 Consumer Discretionary 3.76%
5 Financials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
1001
Arrowhead Research
ARWR
$12.1B
– –
-71,363
Closed -$1.81M
ATAI icon
1002
AtaiBeckley Inc
ATAI
$2.66B
– –
-109,284
Closed -$198K
BCAB icon
1003
BioAtla
BCAB
$5.59M
– –
-622
Closed -$83.4K
BLTE
1004
Belite Bio
BLTE
$6.15B
– –
-15,786
Closed -$458K
BN icon
1005
Brookfield
BN
$102B
– –
-39,749
Closed -$864K
BPMC
1006
DELISTED
Blueprint Medicines
BPMC
– –
-39,523
Closed -$1.78M
BTAI icon
1007
BioXcel Therapeutics
BTAI
$26.2M
– –
-1,154
Closed -$344K
CMPS
1008
Compass Pathways
CMPS
$1.52B
– –
-28,085
Closed -$279K
CNNE icon
1009
Cannae Holdings
CNNE
$647M
– –
-47,600
Closed -$961K
COGT icon
1010
Cogent Biosciences
COGT
$6.79B
– –
-46,045
Closed -$497K
CYTK icon
1011
Cytokinetics
CYTK
$11B
– –
-62,694
Closed -$2.21M
EBS icon
1012
Emergent Biosolutions
EBS
$375M
– –
-33,036
Closed -$342K
KYNB
1013
Kyntra Bio
KYNB
$28.5M
– –
-2,476
Closed -$1.16M
FULC icon
1014
Fulcrum Therapeutics
FULC
$248M
– –
-40,692
Closed -$116K
GNW icon
1015
Genworth Financial
GNW
$3.8B
– –
-19,505
Closed -$97.9K
ICL icon
1016
ICL Group
ICL
$6.81B
– –
-73,830
Closed -$502K
KOD icon
1017
Kodiak Sciences
KOD
$2.59B
– –
-34,462
Closed -$214K
MGNI icon
1018
Magnite
MGNI
$2.65B
– –
-10,106
Closed -$93.6K
MNTK icon
1019
Montauk Renewables
MNTK
$266M
– –
-267,714
Closed -$2.11M
MRUS
1020
DELISTED
Merus
MRUS
– –
-30,513
Closed -$561K
NVAX icon
1021
Novavax
NVAX
$1.23B
– –
-56,775
Closed -$393K
OCGN icon
1022
Ocugen
OCGN
$410M
– –
-149,176
Closed -$127K
OPK icon
1023
Opko Health
OPK
$921M
– –
-509,055
Closed -$743K
RARE icon
1024
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-46,259
Closed -$1.85M
RCKT icon
1025
Rocket Pharmaceuticals
RCKT
$348M
– –
-52,273
Closed -$895K
38 39 40
41
42

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, ALPS Advisors held 1,049 positions worth $11.5B, up 1.7% from $11.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

ALPS Advisors's Q2 2023 filing shows 36 new, 599 increased, 353 reduced and 55 closed positions. Its largest new stake was Nextpower Inc: 131,086 shares worth $5.22M. The largest sale was Magellan Midstream Partners, L.P., an estimated $128M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q2 2023 buy was Nextpower Inc: 131,086 shares worth $5.22M.
  • ALPS Advisors added most to Hess Midstream in Q2 2023, an estimated $60.8M increase.
  • ALPS Advisors's biggest Q2 2023 reduction was Magellan Midstream Partners, L.P., cutting an estimated $128M.
  • ALPS Advisors fully exited Roivant Sciences in Q2 2023, selling an estimated $3.69M.
  • ALPS Advisors's ten largest holdings make up 54% of its $11.5B portfolio in Q2 2023.
  • ALPS Advisors opened 36 new positions and closed 55 in Q2 2023.
  • ALPS Advisors's portfolio value rose 1.7% quarter-over-quarter to $11.5B.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.